Basilea Lands New BARDA Funding for Resistant UTI Antibiotic
ALLSCHWIL, Switzerland — May 28, 2026 Basilea Pharmaceutica announced that the U.S. Biomedical Advanced Research and Development Authority (BARDA),...
antimicrobial resistance
Advertisement
Merz and Kvvit Partner to Expand INBRIJA Access
FRANKFURT, Germany and GANZHOU, China, May 26, 2026 Merz Therapeutics GmbH and Jiangxi Kvvit Pharmaceutical Co. Ltd. have announced...
Lilly Acquires Curevo, LimmaTech and Vaccine Company
INDIANAPOLIS, United States, May 26, 2026 Eli Lilly and Company has announced three major biotechnology acquisitions aimed at significantly...
Meiji Seika Reports Positive Phase III Nacubactam Data
TOKYO, Japan, May 15, 2026 Meiji Seika Pharma Co., Ltd. announced that positive results from the global Phase III...
Biotia Validates AI-NGS Test for Accurate UTI Detection
NEW YORK, April 23, 2026 Biotia announced the publication of a pivotal clinical validation study in the Microbiology Spectrum...
Advertisements
EMA Recommends First RNA-Based Veterinary Vaccine in EU
AMSTERDAM, Netherlands, April 17, 2026 The European Medicines Agency (EMA), through its Committee for Veterinary Medicinal Products (CVMP), has...
BioVersys Starts Phase 3 BV100 Pneumonia Trial
BASEL, Switzerland, April 16, 2026 BioVersys AG has announced a key clinical milestone with the first patient first visit...
Vedanta Biosciences Advances Microbiome Drugs at ESCMID 2026
CAMBRIDGE, Mass., April 9, 2026 Vedanta Biosciences, a late clinical-stage biopharmaceutical company, has announced new scientific presentations showcasing its...
Shionogi Shows Strong Fetroja Real-World Effectiveness
OSAKA, Japan, April 8, 2026 Shionogi & Co., Ltd. presented new real-world clinical data for Fetroja®/Fetcroja® (cefiderocol) at ESCMID...
FDA Grants Breakthrough Status to AMR Rapid Tests
Innovative Diagnostics Target Critical Drug Resistance February 18, 2026 | Santa Maria, California U.S. Food and Drug Administration has...
Advertisement
